Transition Bio Overview
- Founded
-
2020
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$50M
- Investors
-
5
Transition Bio General Information
Description
Operator of a biotechnology company intended to build a hypothesis-free drug discovery and diagnostics platform for human health care advancement. The company harnesses droplet microfluidic approaches and protein biophysics platforms to characterize condensates with unprecedented precision, enabling medical practitioners to map condensates in molecular detail.
Contact Information
Website
www.transitionbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 21 Erie Street
- Suite C
- Cambridge, MA 02139
- United States
+1 (917) 000-0000
Transition Bio Timeline
Transition Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 02-Jun-2022 | $50M | 0000 | 00000 | Completed | Generating Revenue |
| 1. Seed Round | 01-Sep-2020 | 000 | 000 | 0000 | Completed | Startup |
Transition Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.000 | |
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Transition Bio Executive Team (8)
Transition Bio Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Al Sandrock | Self | Board Member | 000 0000 |
| David Weitz Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| David Zimble | Transition Bio | Board Member | 000 0000 |
| George Martin | Self | Board Member | 000 0000 |
| Gregory Miller | Transition Bio | Chief Executive Officer & Board Member | 000 0000 |
Transition Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Transition Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | Corporation | Minority | 000 0000 | 000000 0 | |
| Magnetic Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Northpond Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Taiho Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Lifeforce Capital | Venture Capital | Minority | 000 0000 | 000000 0 |